Itchaway Cream is a topical formulation combining Ciprofloxacin (1% w/w), Metronidazole (1% w/w), Terbinafine (1% w/w), and Clobetasol (0.05% w/w), designed for the effective management of mixed dermatological infections accompanied by inflammation and pruritus. Ciprofloxacin, a broad-spectrum fluoroquinolone antibiotic, targets gram-negative and some gram-positive bacteria by inhibiting bacterial DNA gyrase, thereby preventing bacterial replication. Metronidazole, an antiprotozoal and antibacterial agent, is particularly effective against anaerobic bacteria and certain protozoa by disrupting DNA synthesis. Terbinafine, an allylamine antifungal, inhibits squalene epoxidase, leading to ergosterol depletion and fungal cell membrane disruption, making it effective against dermatophytes and other fungal pathogens. Clobetasol propionate, a potent corticosteroid, exerts anti-inflammatory, antipruritic, and vasoconstrictive effects by modulating inflammatory mediators and immune responses. The combination of these agents in Itchaway Cream provides a broad-spectrum antimicrobial effect alongside rapid symptomatic relief from inflammation and itching, making it suitable for complex infections involving bacterial, protozoal, and fungal etiologies with associated dermatitis. It is intended for topical use only and should be applied as directed by a healthcare professional, avoiding prolonged use to minimize potential corticosteroid-related adverse effects.